Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Haichuan Hu, Ph.D.

Concepts

This page shows the publications Haichuan Hu has written about Aged.
Connection Strength

0.056
  1. Is anterior mediastinum route a shorter choice for esophageal reconstruction? A comparative anatomic study. Eur J Cardiothorac Surg. 2011 Dec; 40(6):1466-9.
    View in: PubMed
    Score: 0.012
  2. Extended Right Thoracic Approach Compared With Limited Left Thoracic Approach for Patients With Middle and Lower Esophageal Squamous Cell Carcinoma: Three-year Survival of a Prospective, Randomized, Open-label Trial. Ann Surg. 2018 05; 267(5):826-832.
    View in: PubMed
    Score: 0.005
  3. Analysis of major known driver mutations and prognosis in resected adenosquamous lung carcinomas. J Thorac Oncol. 2014 Jun; 9(6):760-8.
    View in: PubMed
    Score: 0.004
  4. FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer. Clin Cancer Res. 2014 Aug 01; 20(15):4107-14.
    View in: PubMed
    Score: 0.004
  5. PIK3CA mutations frequently coexist with EGFR/KRAS mutations in non-small cell lung cancer and suggest poor prognosis in EGFR/KRAS wildtype subgroup. PLoS One. 2014; 9(2):e88291.
    View in: PubMed
    Score: 0.004
  6. Prevalence, clinicopathologic characteristics, and molecular associations of EGFR exon 20 insertion mutations in East Asian patients with lung adenocarcinoma. Ann Surg Oncol. 2014 Dec; 21 Suppl 4:S490-6.
    View in: PubMed
    Score: 0.004
  7. ALK-rearranged lung cancer in Chinese: a comprehensive assessment of clinicopathology, IHC, FISH and RT-PCR. PLoS One. 2013; 8(7):e69016.
    View in: PubMed
    Score: 0.003
  8. ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S577-82.
    View in: PubMed
    Score: 0.003
  9. RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer. J Clin Oncol. 2012 Dec 10; 30(35):4352-9.
    View in: PubMed
    Score: 0.003
  10. Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose. Lung Cancer. 2013 Jan; 79(1):8-13.
    View in: PubMed
    Score: 0.003
  11. Pattern of lymphatic spread in thoracic esophageal squamous cell carcinoma: A single-institution experience. J Thorac Cardiovasc Surg. 2012 Oct; 144(4):778-85; discussion 785-6.
    View in: PubMed
    Score: 0.003
  12. Frequency of driver mutations in lung adenocarcinoma from female never-smokers varies with histologic subtypes and age at diagnosis. Clin Cancer Res. 2012 Apr 01; 18(7):1947-53.
    View in: PubMed
    Score: 0.003
  13. Lung adenocarcinomas with HER2-activating mutations are associated with distinct clinical features and HER2/EGFR copy number gains. J Thorac Oncol. 2012 Jan; 7(1):85-9.
    View in: PubMed
    Score: 0.003
  14. A high-quality secretome of A549 cells aided the discovery of C4b-binding protein as a novel serum biomarker for non-small cell lung cancer. J Proteomics. 2011 Apr 01; 74(4):528-38.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.